Open access
Aug 2026
The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study.
LDL-C <55 mg/dL was associated with lower cardiovascular mortality in ESKD, supporting further investigation into very low LDL-C targets in this population and supporting further investigation into very low LDL-C targets in this population of patients.
C. Yen, Pei-Chun Fan, Jia-Jin Chen et al.
· Atherosclerosis · 0 citations